Princeton Alpha Management’s Ionis Pharmaceuticals IONS Stock Holding History

Princeton Alpha Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,400	Closed	-$1.07M	–	642
2016 Q4	$1.07M	Buy	+22,400	New	+$886K	0.22%	129
2015 Q3	–	Sell	-43,983	Closed	-$2.53M	–	807
2015 Q2	$2.53M	Buy	43,983 +32,026	+268%	+$2.04M	0.5%	29
2015 Q1	$761K	Buy	+11,957	New	+$811K	0.16%	177

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Princeton Alpha Management's IONS Position: Q1 2017 in Review

Princeton Alpha Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 22,400 shares — an estimated $1.07M sold.

Princeton Alpha Management first reported a position in IONS in Q1 2015 and held it in 3 quarters. The position peaked at $2.53M in Q2 2015. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

Princeton Alpha Management reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Princeton Alpha Management sold 22,400 Ionis Pharmaceuticals shares in Q1 2017, an estimated $1.07M.
Princeton Alpha Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Princeton Alpha Management's Ionis Pharmaceuticals position peaked at $2.53M in Q2 2015.
270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.